ARCHIVES

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

ASCO Honors Eight With Special Awards

May 24, 2002

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997